Osteogenesis imperfecta (OI), also known as brittle bone disease, is a rare genetic disease ... Signs and symptoms range from mild to severe.[1-3] There are eight types of OI, and the ...

Mereo’s drug candidate for brittle bone disease missed its primary endpoint ... If it does get approved, that could translate into a $1 billion-plus market opportunity for the drug, based ...

Baylor College of Medicine is conducting this OI Wellbeing Study as a part of the Brittle Bone Disease Consortium which aims to improve ... over a secure teleconference platform for about 1 hour and ...